Methotrexate (MTX) as a first-line drug to cure Rheumatoid Arthritis,has good effect to anti-inflammatory, immunomodulatory and anti-proliferative, its satisfaction with the efficiency / toxicity ratio has been confirmed.
甲氨喋呤(MTX)作为一线治疗类风湿性关节炎的药物,具有良好的抗炎、免疫调节和抗增殖作用,其满意的效益/毒性比已经得到证实。
参考来源 - 甲氨喋呤对兔动脉粥样硬化模型干预效果的实验研究·2,447,543篇论文数据，部分数据来源于NoteExpress
The clinical efficacy, thermal enhancement ratio and toxicity were compared in two groups respectively.
分别比较两组的近期疗效和毒性反应，并计算热增强比。
No obvious diversity (P>0.05) was found by comparing the negative control group with the short-term toxicity test group in terms of weight, food-intake, food utilizing ratio of the mice;
短期毒性试验的动物体重、进食量、食物利用率与阴性对照组比较，差异均无显著性（P>0.05）；
应用推荐